| 000 | 01547 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517144519.0 | ||
| 264 | 0 | _c20170823 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1743-422X | ||
| 024 | 7 |
_a10.1186/s12985-017-0708-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Yanhua | |
| 245 | 0 | 0 |
_aSVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China. _h[electronic resource] |
| 260 |
_bVirology journal _c03 2017 |
||
| 300 |
_a62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aInterferons |
| 650 | 0 | 4 |
_aInterleukins _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWang, Jiuping | |
| 700 | 1 | _aWang, Juan | |
| 700 | 1 | _aXiao, Yunfeng | |
| 700 | 1 | _aXu, Bin | |
| 700 | 1 | _aLi, Hongwei | |
| 700 | 1 | _aYang, Liu | |
| 700 | 1 | _aHao, Xiaoke | |
| 700 | 1 | _aMa, Yueyun | |
| 773 | 0 |
_tVirology journal _gvol. 14 _gno. 1 _gp. 62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12985-017-0708-6 _zAvailable from publisher's website |
| 999 |
_c27009068 _d27009068 |
||